Analysis of risk factors of rapid thyroidal radioiodine-131 turnover in Graves’ disease patients
Abstract Rapid iodine-131(131I) turnover in the thyroid gland is an important feature of Graves’ disease (GD) and also a strong predictor of radioiodine therapy failure. The aim of this study was to explore the predictors of rapid 131I turnover. The clinical data on 2543 patients were retrospectivel...
Guardado en:
Autores principales: | Ruiguo Zhang, Jian Tan, Renfei Wang, Guizhi Zhang, Qiang Jia, Zhaowei Meng, Yueqian Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ba226b8837c7421fa08a5c7c9d4aa19c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Delayed Initial Radioiodine Adjuvant Therapy Does Affect Biochemical Response in Intermediate- to High-Risk Differentiated Thyroid Cancer
por: Feng Yu, et al.
Publicado: (2021) -
The effect of radioiodine treatment on the characteristics of TRAb in Graves’ disease
por: Ya Fang, et al.
Publicado: (2021) -
Improving 131I Radioiodine Therapy By Hybrid Polymer-Grafted Gold Nanoparticles
por: Le Goas M, et al.
Publicado: (2019) -
Occupational exposure and radiobiological risk from thyroid radioiodine therapy in Saudi Arabia
por: H. I. Al-Mohammed, et al.
Publicado: (2021) -
Oxidative stress and radioiodine treatment of differentiated thyroid cancer
por: Angelika Buczyńska, et al.
Publicado: (2021)